2. Academic Validation
  3. Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes

Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes

  • J Med Chem. 2022 Sep 8;65(17):11818-11839. doi: 10.1021/acs.jmedchem.2c00926.
Yun Wu 1 2,  Ziping Qi 1 2,  Beilei Wang 1 2,  Junjie Wang 1 3,  Qingwang Liu 1 2,  Aoli Wang 1 2,  Chenliang Shi 1 3,  Bin Zhou 1 3,  Qianmao Liang 1 3,  Wenliang Wang 1 4,  Fengming Zou 1 2,  Shuang Qi 1 2,  Zuowei Wang 1 3,  Li Wang 1 2,  Wenchao Wang 1 2 3,  Jing Liu 1 2 3,  Qingsong Liu 1 2 3 4
Affiliations

Affiliations

  • 1 Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui 230031, P. R. China.
  • 2 Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, Anhui 230031, P. R. China.
  • 3 University of Science and Technology of China, Hefei, Anhui 230026, P. R. China.
  • 4 Precision Medicine Research Laboratory of Anhui Province, Hefei, Anhui 230088, P. R. China.
PMID: 36037148 DOI: 10.1021/acs.jmedchem.2c00926
Abstract

The critical pathogenesis of type 1 diabetes (T1D)/type 2 diabetes (T2D) is the physical status, mass, and function of pancreatic β cells. Mammalian STE20-like protein 1 kinase (MST1) plays vital roles in the Apoptosis and Insulin secretion of β cells. Here, we discovered a novel, potent, and selective MST1 inhibitor 19 (IC50 = 23 nM), which inhibited the phosphorylation of MST1-protected β cells from the damage of inflammatory cytokines in vitro. In vivo, it displayed acceptable pharmacokinetic properties in different species. In the STZ-induced T1D/T2D mouse models, both monotherapy of 19 and in combination with metformin led to the decline of fasting blood glucose and showed protective effect of β cells. In addition, the combination of 19 and metformin decreased the hemoglobin A1c level. Together, our study suggested that 19 might be a useful pharmacological tool to study MST1-mediated physiology and pathology as well as a potential drug candidate for diabetes.

Figures
Products